Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
2/28/2024
NHSA Study Affirms Generic Metformin Effectiveness in China's Bulk Buy...
2/28/2024
AstraZeneca Chooses Shanghai as Fifth Global Strategic Center, Reinfor...
2/27/2024
NHSA Releases A List of Pharma Companies with Serious Bad Faith Practi...
2/26/2024
BeiGene Ends Partnership with Shoreline in Cell Therapy Venture
2/26/2024
Beijing Haidian District Unveils Measures to Boost High-Quality Develo...
2/26/2024
The Uneven Distribution of Medical Resources for Severe Diseases in Ch...
2/26/2024
Danone Report Robust China Growth, Fueled by Infant and Medical Nutri...
2/26/2024
China's Online Healthcare Sector Shows Robust Growth and Evolving User...
2/26/2024
Mabwell Terminates Licensing Deals with Yangtze River Pharma for Two C...
2/26/2024
Chinese Researchers Made Breakthrough in Biosynthesis of Anticancer Pa...
2/26/2024
Chinese Pharma R&D Investment Grew by Nearly 20% in 2023
2/26/2024
CDE Introduces a Legal Document Submission Module on the Patent Inform...
2/26/2024
Despite Challenges, German MNCs Plans Increased Investments in China
2/26/2024
Nhwa Pharma Licenses China Commericialization Rights of Teva's AUSTEDO...
2/23/2024
Drug R&D and Product Registration News Digest February 2024 (2)
2/23/2024
Recent Official and Executive Moves
2/23/2024
NMPA Issues the Rules for the Application of Discretion in Administra...
2/22/2024
CDE Issues the Technical Guidelines for Non-Clinical Research on Enzym...
2/22/2024
Narrowly Tailored U.S. Bill Targeting Chinese Biotech Companies Sparks...
2/22/2024
Domestic Drugmakers Showcased Remarkable Innovation and Global Expansi...
2/21/2024
CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...
2/21/2024
CDE Issues the Technical Guidelines for Pharmaceutical Research and Ev...
2/21/2024
Sinopharm Offers to Take HK-listed China-TCM Private in Nearly US$3B D...
2/21/2024
Chinese Experts Uncovers Potential Treatment for Osteoporosis in Femal...
2/21/2024
CDE Publicizes the List of Reference Formulations for GQCE Studies (79...
2/21/2024
China to Establish Organization for Poliovirus Control and Biosecurity...
2/20/2024
AlphaGen and ARTBIO Announce Strategic Deal for the Development and Co...
2/19/2024
Trends in the Disease Burden of Anxiety Disorders in Middle-Aged and O...
2/19/2024
The Chinese Oncology Drug Market Projected to Grow at CAGR 8.75% by ...
2/19/2024
Everest Ends Covid-19 Vaccine Deal With Canada's Providence
Page:
37
/
41
Total number of articles:
1204
:
[First]
[<<]
[35]
[36]
[37]
[38]
[39]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit